The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
Open accessAbstract
PURPOSE: This multidisciplinary, evidence-based guideline for clinically non-metastatic muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of muscle-invasive bladder cancer guided toward curative intent. MATERIALS AND METHODS: A systematic review utilizing research from the Agency for Healthcare Research and Quality as well as additional supplementation by the authors and consultant methodologists was used to develop the guideline. Evidence-based statements were based on body of evidence strengths Grade A, B or C and were designated as Strong, Moderate and Conditional Recommendations with additional statements presented in the form of Clinical Principles or Expert Opinions. RESULTS: For the first time for any type of malignancy, the American Urological Association, American Society of Clinical Oncology, American Society for Radiation Oncology and Society of Urologic Oncology have formulated an evidence-based guideline based on a risk-stratified clinical framework for the management of muscle-invasive urothelial bladder cancer. This document is designed to be used in conjunction with the associated treatment algorithm. CONCLUSIONS: The intensity and scope of care for muscle-invasive bladder cancer should focus on the patient, disease and treatment response characteristics. This guideline attempts to improve a clinician's ability to evaluate and treat each patient, but higher quality evidence in future trials will be essential to improve level of care for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Burger, M., Catto, J. W. F., Dalbagni, G., Grossman, H. B., Herr, H., Karakiewicz, P., Kassouf, W., Kiemeney, L. A., La Vecchia, C., Shariat, S., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.07.033 · Cited by 2,164
Self-citationShabsigh, A., Korets, R., Vora, K. C., Brooks, C. M., Cronin, A. M., Savage, C., Raj, G., Bochner, B. H., Dalbagni, G., Herr, H. W., et al. (2009) · European Urology · doi:10.1016/j.eururo.2008.07.031 · Cited by 1,400
Self-citationAssociation Between Smoking and Risk of Bladder Cancer Among Men and Women
Freedman, N. D. (2011) · JAMA · doi:10.1001/jama.2011.1142 · Cited by 1,141
Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J. D., Real, F. X., Van Den Berg, D., Matullo, G., Baris, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.687 · Cited by 481
Coppin, C., Gospodarowicz, M. K., James, K. W., Tannock, I. F., Zee, B. C.-Y., Carson, J., Pater, J. L., & Sullivan, L. D. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.2901 · Cited by 472
Leow, J. J., Martin-Doyle, W., Rajagopal, P. S., Patel, C. G., Anderson, E. M., Rothman, A. T., Cote, R. J., Urun, Y., Chang, S. L., Choueiri, T. K., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.033 · Cited by 411
Self-citationGalsky, M. D., Hahn, N. M., Rosenberg, J., Sonpavde, G., Hutson, T., Oh, W. K., Dreicer, R., Vogelzang, N., Sternberg, C., Bajorin, D. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70275-8 · Cited by 356
Self-citationKoppie, T. M., Serio, A. M., Vickers, A. J., Vora, K., Dalbagni, G., Donat, S. M., Herr, H. W., & Bochner, B. H. (2008) · Cancer · doi:10.1002/cncr.23462 · Cited by 352
Self-citationNeoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.
Herr, H. W., Bajorin, D. F., & Scher, H. I. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1298 · Cited by 203
Samanic, C., Kogevinas, M., Dosemeci, M., Malats, N., Real, F. X., Garcia-Closas, M., Serra, C., Carrato, A., García-Closas, R., Sala, M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0021 · Cited by 187
Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
Culp, S. H., Dickstein, R. J., Grossman, H. B., Pretzsch, S. M., Porten, S., Daneshmand, S., Cai, J., Groshen, S., Siefker-Radtke, A., Millikan, R. E., et al. (2014) · Journal of Urology · doi:10.1016/j.juro.2013.07.061 · Cited by 178
Self-citationHOLZBEIERLEIN, J. M., LOPEZ-CORONA, E., BOCHNER, B. H., HERR, H. W., DONAT, S. M., RUSSO, P., DALBAGNI, G., & SOGANI, P. C. (2004) · Journal of Urology · doi:10.1097/01.ju.0000135530.59860.7d · Cited by 173
Self-citationMuscle‐invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base
Smith, A. B., Deal, A. M., Woods, M. E., Wallen, E. M., Pruthi, R. S., Chen, R. C., Milowsky, M. I., & Nielsen, M. E. (2014) · BJU International · doi:10.1111/bju.12601 · Cited by 171
Collins, J. W., Patel, H., Adding, C., Annerstedt, M., Prokar Dasgupta, A., Khan, S., Artibani, W., Gastón, R., Piéchaud, T., Catto, J. W. F., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.020 · Cited by 145
Guidelines on Bladder Cancer Muscle-invasive and Metastatic
Stenzl, A., Compérat, É., Santis, M. D., Kuczyk, M. A., Lebrét, T., & Sherif, A. M. (2008) · Cited by 78
The characteristics of bladder cancer after radiotherapy for prostate cancer
Abern, M. R., Dude, A., Tsivian, M., & Coogan, C. L. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.04.006 · Cited by 70
Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
Vale, C. L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006018 · Cited by 67
Cited by
Lenis, A. T., Lec, P. M., Chamie, K., & MSHS, M. (2020) · JAMA · doi:10.1001/jama.2020.17598 · Cited by 2,051
Dyrskjøt, L., Hansel, D. E., Efstathiou, J. A., Knowles, M. A., Galsky, M. D., Teoh, J., & Theodorescu, D. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00468-9 · Cited by 544
Boorjian, S. A., Alemozaffar, M., Konety, B. R., Shore, N. D., Gomella, L. G., Kamat, A. M., Bivalacqua, T. J., Montgomery, J. S., Lerner, S. P., Busby, J. E., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30540-4 · Cited by 480
Self-citationBellmunt, J., Hussain, M., Gschwend, J. E., Albers, P., Oudard, S., Castellano, D., Daneshmand, S., Nishiyama, H., Majchrowicz, M., Degaonkar, V., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00004-8 · Cited by 429
Self-citationBladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Spiess, P. E., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Clark, P. E., Downs, T. M., Efstathiou, J. A., Flaig, T. W., Friedlander, T., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0156 · Cited by 268
Self-citation
Metadata
- Authors
- Chang, S. S., Bochner, B. H., Chou, R., Dreicer, R., Kamat, A. M., Lerner, S. P., Lotan, Y., Meeks, J. J., Michalski, J. M., Morgan, T. M., Quale, D. Z., Rosenberg, J. E., Zietman, A. L., & Holzbeierlein, J. M.
- Venue
- Journal of Urology
- Published
- 2017-09
- Volume
- 198
- Issue
- 3
- Pages
- 552-559
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2609787832
- Cited by
- 938
- References
- 18
- FWCI
- 76.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.